Clinical Trial Update: Target Engagement for Oxytocin: Dose Ranging Study [NA]

View source ↗

Summary

This clinical trial update reports results from a dose-ranging study evaluating oxytocin target engagement in individuals with schizophrenia spectrum. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia Spectrum

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Schizophrenia Spectrum | NA | Status: COMPLETED | Results posted: 2019-01-31